Pharmacokinetic Modeling Identifies Optimal Fludarabine Exposure for Improved Outcomes Following Allogeneic Transplantation with Post-Transplant Cyclophosphamide

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Mohammad Alhomoud, Miguel‐Angel Perales, David Nemirovsky, Glenn Heller, Andrew P. Lin, Parastoo Bahrami Dahi, Moneeza Walji, Gunjan L. Shah, Ioannis Politikos, Charlotte Hughes, Gagan Raju, Sandeep Raj
+9 more Richard Jirui Lin, Ann Alice Jakubowski, Esperanza Bouza Papadopoulos, Doris M. Ponce, Craig Steven Sauter, Roni Tamari, Sergio A. Giralt, Brian C. Shaffer, Michael Scordo
DOI: 10.1016/j.jtct.2025.12.186
Cited by: 0

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Renal Transplantation Outcomes and Treatments Pharmaceutical studies and practices

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S138–S139
Publication date
1 February 2026
Language
EN